D.E. Shaw & Co’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-155,495
| Closed | -$280K | – | 3948 |
|
|
2022
Q3 | $280K | Sell |
155,495
-423,392
| -73% | -$762K | ﹤0.01% | 3098 |
|
|
2022
Q2 | $1.68M | Sell |
578,887
-223,620
| -28% | -$649K | ﹤0.01% | 2366 |
|
|
2022
Q1 | $2.22M | Buy |
802,507
+358,750
| +81% | +$990K | ﹤0.01% | 2354 |
|
|
2021
Q4 | $2.07M | Buy |
+443,757
| New | +$2.07M | ﹤0.01% | 2352 |
|
|
2021
Q3 | – | Sell |
-55,350
| Closed | -$908K | – | 3987 |
|
|
2021
Q2 | $908K | Sell |
55,350
-33,040
| -37% | -$542K | ﹤0.01% | 2558 |
|
|
2021
Q1 | $1.95M | Buy |
+88,390
| New | +$1.95M | ﹤0.01% | 1862 |
|